Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
BioTelemetry (BEAT) Shows Strength: Stock Moves 8.8% Higher
BioTelemetry, Inc. (BEAT - Free Report) was a big mover last session, as the company saw its shares rise almost 9% on the day. The move came after the company announced the acquisition of LifeWatch. This led to far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $26.00 to $29.10 in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioTelemetry currently holds a Zacks Rank #2 (Buy).
BioTelemetry, Inc. Price
BioTelemetry, Inc. Price | BioTelemetry, Inc. Quote
Another top stock in the Medical Services industry is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is BEAT going up? Or down? Predict to see what others think: Up or Down
Looking for Ideas with Even Greater Upside?
Most of Zacks’ investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information>>